Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Long-Term Debt Issuances (2021 - 2025)

Pasithea Therapeutics' (KTTAW) quarterly Long-Term Debt Issuances came in at $179310.0 in Q1 2025, down 54.3% quarter-over-quarter from $392354.0 in Q1 2023.

Analysis

Pasithea Therapeutics Corp. (KTTAW) Long-Term Debt Issuances (2021 - 2025) Analysis & Trends

Pasithea Therapeutics has disclosed Long-Term Debt Issuances across 3 years of filings, most recently posting $179310.0 for Q1 2025.

  • In Q1 2025, Long-Term Debt Issuances changed N/A year-over-year to $179310.0; the TTM figure through Mar 2025 stood at $179310.0 (changed N/A YoY), while the FY2023 annual figure was $392354.0, changed N/A from the prior year.
  • Long-Term Debt Issuances came in at $179310.0 for Q1 2025 at Pasithea Therapeutics, down from $392354.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $20.7 million in Q3 2021 to a low of $179310.0 in Q1 2025.
  • Average Long-Term Debt Issuances over 3 years is $5.5 million, with a median of $1.2 million recorded in 2021.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 179,310.00
Mar 31, 2023 392,354.00
Dec 31, 2021 5.30 Mn
Sep 30, 2021 20.65 Mn
Mar 31, 2021 1.21 Mn